Skip to content
Pharma’s next trip: The industry alters its state of mind on psychedelics. Will psychedelics provide a future for mental health drug development?

Details

  • Main Stage
Date:
11/05/2022
Start Time:
4:45 pm
End Time:
17:40

Dr. Bill W. Massey, PhD

CEO & Founder, Ninnion Therapeutics

Bill Massey is a world-renowned neuropharmacologist, pharmacogeneticist, life sciences professional, inventor, and entrepreneur. His primary focus is developing new CNS therapeutics. Under his supervi…

James Kuo, MD, MBA

Vice President of R&D, Silo Pharma

Dr. James (Jim) Kuo currently serves as Vice President of R&D at Silo Pharma. In addition, he is Managing Director of Athena Bioventures, Chairman of the board of ImmunoPrecise Antibodies and a board …

Adam Coape-Arnold

CEO / Founder, Cubed Biotech Inc

Adam B. Coape-Arnold is the CEO and Founder of Cubed Biotech Inc. He has a decade of experience owning and operating premium brands in the regulated industries of raw dairy, yogurt, and cannabis, with…

Get Recordings Now!

Easily access the recordings for your favorite Wonderland sessions, allowing you to revisit the discussions and insights shared by our visionary speakers.

Buy Now